Yahoo Finance Live continues to break down the economic data released in today's May jobs report, unemployment rates indicated by race, the labor force participation rate, and which companies are planning hiring freezes or worker cutbacks amid recession worries. Read More...
Motley Fool
Why Shares of Amarin Corporation Dropped 46.1% in May
Amarin Corporation (NASDAQ: AMRN), a biopharmaceutical company that specializes in cardiovascular therapies, saw its shares plummet 46.1% in May, according to data from S&P Global Market Intelligence. The company has only one marketed therapy, Vascepa (icosapent ethyl), which is designed to reduce the risk of stroke or heart attack by lowering harmful triglycerides, a type of fat in your blood. The problem for Amarin is that Vascepa now has three generic competitors compared to only one at this time last year.
